BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18676750)

  • 1. Three-gene expression signature predicts survival in early-stage squamous cell carcinoma of the lung.
    Skrzypski M; Jassem E; Taron M; Sanchez JJ; Mendez P; Rzyman W; Gulida G; Raz D; Jablons D; Provencio M; Massuti B; Chaib I; Perez-Roca L; Jassem J; Rosell R
    Clin Cancer Res; 2008 Aug; 14(15):4794-9. PubMed ID: 18676750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
    Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
    Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
    Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
    Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
    Kim SJ; Shin HJ; Jung KY; Baek SK; Shin BK; Choi J; Kim BS; Shin SW; Kim YH; Kim JS; Oosterwijk E
    Jpn J Clin Oncol; 2007 Nov; 37(11):812-9. PubMed ID: 18057013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: a pilot study.
    Zhu Y; Zhou XY; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Ye DW
    Urol Oncol; 2013 Jul; 31(5):706-11. PubMed ID: 21664839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
    Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
    J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
    J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Cox G; O'Byrne KJ
    Br J Cancer; 2004 Oct; 91(7):1301-7. PubMed ID: 15365565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts.
    Noro R; Ishigame T; Walsh N; Shiraishi K; Robles AI; Ryan BM; Schetter AJ; Bowman ED; Welsh JA; Seike M; Gemma A; Skaug V; Mollerup S; Haugen A; Yokota J; Kohno T; Harris CC
    J Thorac Oncol; 2017 Jan; 12(1):65-76. PubMed ID: 27613525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
    Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
    Måseide K; Kandel RA; Bell RS; Catton CN; O'Sullivan B; Wunder JS; Pintilie M; Hedley D; Hill RP
    Clin Cancer Res; 2004 Jul; 10(13):4464-71. PubMed ID: 15240538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
    Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.